- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03896386
EPIDOGS Digital Seizure Diary for Owners of Alerting Dogs
Investigation of Behaviour by Dogs Prior to Human Epileptic Seizures and Potential Underlying Mechanisms: EPIDOGS Digital Seizure Diary
Study Overview
Detailed Description
This is a international study by Ghent University that will initially involve people from Belgium, Italy and the UK.
Previous studies of alerting dog accuracy are either case studies or retrospective studies that rely on memory recall of information about alerting behaviour, with the risk of memory bias that reduces reliability.
The use of electronic diaries has been described as more accurate and has better compliance than paper ones. Nowadays, electronic diaries offer the possibility of receiving live information and/or timed answers, thereby increasing compliance and decreasing the incidence of memory bias. This would be the first time that "real time" information about dog behaviour and seizures in the same patients is collected systematically. This will facilitate the analysis of the specificity and sensitivity of alerting behaviour as perceived by the owner.
During a three-month period, systematic data on the occurrence of seizures in the patient and on alerting behaviour by the dog will be collected. This information will increase the knowledge of the type of alerting behaviours that the dogs display and will allow to calculate the specificity and sensitivity of dog behaviour interpreted by the owner as predictive of a seizure. Depending on availability of trained and untrained dogs, possible differences in the alerting behaviour between both types of dogs and in their alerting specificity/sensitivity will be studied.To avoid recall bias the information will be received live through a back-end.
To be able to participate, the volunteers will grant the investigators permission, via the informed consent, to contact their neurologist to confirm their epilepsy diagnosis and to send monthly reports of the electronic diary (see below) to their neurologist.
It will be stated clearly in the instructions and the informed consent that the purpose of the app is to collect data to investigate dog behaviour and that the app is not intended as a monitoring tool for the patient. In the instructions and informed consent the investigators will be insisting that the volunteers only use the app when they are in a safe position or/and have recovered fully from the seizure.
The documents will also include a recommendation to contact their neurologist should a sudden change in the frequency or duration of the seizures occur. In addition, the research team will provide monthly reports of the volunteers' electronic diary to their treating neurologists. Before the start of the study, Prof. De Herdt will contact the treating neurologist to inform them and to confirm the epilepsy diagnosis.
Electronic Diary
A smartphone app for Android and iOS will be developed with a main focus on user-friendliness. The App's main screen will display two buttons. The first button is to add alert events by the dog (= behaviour interpreted by the owner as an alert), i.e., to indicate that the dog has alerted. The second button is to add a seizure event (= to indicate a seizure is occurring or has just occurred). A calendar will show the alert and seizure entries on each day. When one of the two buttons is pressed, the time at which this occurred will be registered. It will not be possible to change the entry time, but the patient will have the option to indicate if the seizure happened at a time different from the time of the entry by accessing the seizure entry on the calendar. Once 24 hours have passed, the seizure entry can no longer be modified.
When the patient does not enter any seizure for a whole day, a notification will appear the morning after to ask to confirm that there were no seizures during the previous day. Extra information about the presence/absence of auras and/or prodromi can be entered during the 24 hours after a seizure occurred, by accessing the seizure entry on the calendar. Data introduction and storage will be possible even without internet connection. The data will be uploaded to a database as soon as the phone is connected to a Wi-Fi signal. Compliance will be monitored and patients that are not filling in information regularly (at least once a week, but depending on the frequency with which they experience seizures) will be contacted to verify whether there are any problems using the App and to resolve potential problems.
Data management and informed consent
The collected data will be treated in accordance with the General Data Protection Regulation (EU) 2016/679. The back-end will be SSL certificated and the data will be processed only via the Athena platform and will never be stored or processed locally. The data will be anonymized for analysis, and the database of patients will be coded and stored also in the UGent central IT environment. The database will only be accessed by the supervising team from Ghent University.
The patients will have the right to request information about the state and usage of their data and to request to modify or remove their data from the database at any point. All personal information that could allow us to identify the patient will be destroyed at the end of the study.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Flandes
-
Ghent, Flandes, Belgium, 9000
- Department of Neurology - Ghent University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- The volunteer has been diagnosed with epilepsy by a neurologist and lives with a dog that anticipates the occurrence of seizures (trained or not)
- Volunteers should be able to operate an electronic diary app on a smartphone by themselves or will have an assistant/carer with them 24/24 that will operate the device for them.
- In the case of children, the parents/tutors will fill in the diary for them.
- In the case of people with learning disabilities, carers or familiars will fill in the diary for them.
Exclusion Criteria:
- People with non-epileptic seizures, that are not able to use a smartphone's app or that can't provide us with a confirmation of their diagnosis.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Use of seizure diary
People diagnosed with epilepsy that lives with a dog that is able to anticipate the onset of a seizure.
They will be ask to use a diary (bespoke smartphone app) to register the occurrence of seizures and the alerting behaviour of the dogs.
|
The participants will press the "alert" button when they witness and alerting behaviour on their dogs or the "Seizure" button when they had experienced a seizure.
We will receive this information live through the app back-end
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sensitivity and specificity across all dogs.
Time Frame: 3 months
|
Percentage of dog alerts followed by a seizure, percentage of seizures preceded by a dog alert
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Differences between trained and untrained dogs
Time Frame: 3 months
|
Information on potential differences in in the type of alerting behaviour displayed, sensitivity and specificity between trained and not trained dogs (if enough data are available).
|
3 months
|
|
Correlation between alerting behaviour and pre-ictal symptoms
Time Frame: 3 months
|
A possible correlation between alerting behaviour and the presence of auras and/or prodromi may also be explored.
|
3 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Christel Moons, PhD, Faculty of Veterinary Medicine, Ghent
Publications and helpful links
General Publications
- Stone AA, Shiffman S, Schwartz JE, Broderick JE, Hufford MR. Patient compliance with paper and electronic diaries. Control Clin Trials. 2003 Apr;24(2):182-99. doi: 10.1016/s0197-2456(02)00320-3.
- Brown SW, Goldstein LH. Can Seizure-Alert Dogs predict seizures? Epilepsy Res. 2011 Dec;97(3):236-42. doi: 10.1016/j.eplepsyres.2011.10.019. Epub 2011 Nov 1.
- McEntegart D. Are electronic diaries useful for symptoms research? A systematic review. J Psychosom Res. 2007 Oct;63(4):453. doi: 10.1016/j.jpsychores.2007.08.003. No abstract available.
- Kirton A, Winter A, Wirrell E, Snead OC. Seizure response dogs: evaluation of a formal training program. Epilepsy Behav. 2008 Oct;13(3):499-504. doi: 10.1016/j.yebeh.2008.05.011. Epub 2008 Jul 1.
- Flegg PJ. Seizure-alerting and -response behaviors in dogs living with epileptic children. Neurology. 2005 Feb 8;64(3):581; author reply 581. doi: 10.1212/wnl.64.3.581. No abstract available.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- EC/2018/0232
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Epilepsy
-
NaviFUS CorporationTaipei Veterans General Hospital, TaiwanCompletedDrug Resistant Epilepsy | Epilepsy, Drug Resistant | Intractable Epilepsy | Refractory Epilepsy | Drug Refractory Epilepsy | Epilepsy, Drug Refractory | Epilepsy, Intractable | Medication Resistant EpilepsyTaiwan
-
Great Ormond Street Hospital for Children NHS Foundation...Active, not recruitingEpilepsies, Partial | Intractable Epilepsy | Focal Epilepsy | Refractory Epilepsy | Epilepsy Intractable | Epilepsy in Children | Epilepsy, FocalUnited Kingdom
-
University of British ColumbiaTerminatedJuvenile Myoclonic Epilepsy | Childhood Absence Epilepsy | Juvenile Absence EpilepsyCanada
-
UCB Pharma SACompletedEpilepsy, Tonic-clonicPoland, Sweden, Hungary, Czechia
-
UCB PharmaCompletedEpilepsy, Tonic-clonic
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Oslo University HospitalCompletedEpilepsy | Generalized Epilepsy | Focal EpilepsyNorway
-
Institute of Child HealthGreat Ormond Street Hospital for Children NHS Foundation TrustNot yet recruitingEpilepsy Intractable | Epilepsy in Children
-
University Hospital, LilleCompletedFocal Epilepsy | Epilepsy IntractableFrance
-
Massachusetts General HospitalBoston University; National Institute of Neurological Disorders and Stroke...CompletedEpilepsy | Epilepsy; Seizure | Rolandic Epilepsy | Rolandic Epilepsy, Benign | Centrotemporal Epilepsy | Centrotemporal; EEG Spikes, Epilepsy of ChildhoodUnited States
Clinical Trials on Use of seizure diary
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting
-
University Hospital Schleswig-HolsteinZealand University HospitalTerminated
-
University of BarcelonaRecruitingDepression | Quality of Life | Stress | Anxiety | Intensive Care Unit | Family | Patient | PICS | Diary (Blank Journal)Spain
-
Noema Pharma AGCompletedTrigeminal NeuralgiaUnited States, United Kingdom
-
Hospices Civils de LyonCompletedSeizures | Hyponatremia | BronchiolitisFrance
-
Herlev HospitalOdense University Hospital; Aarhus University Hospital; Danish Head and Neck...TerminatedHead and Neck Neoplasms | Weight LossDenmark
-
The University of QueenslandCompletedAge Related Macular Degeneration | Lutein and Zeaxanthin Dietary Intake | Blue Light Exposure | Electronic Device UseAustralia
-
University of WashingtonErgomed; OctapharmaRecruiting
-
Johns Hopkins UniversityNational Eye Institute (NEI); Results Group LLCTerminatedAge-related Macular DegenerationUnited States